ASX-LISTED pharmaceutical manufacturer Palla Pharma has announced a purchase order for a minimum of 10 tonnes of codeine phosphate to be delivered in 2020 to "a major European tablet producer".
Palla Pharma describes itself as a "low-cost producer of Narcotic Raw Materials," and is one of three fully integrated opiates manufacturers supplying to the global pain relief market, ranging from poppy straw growing right through to tableting.
The contract is worth over US$3 million "and is indicative of our underlying ability to supply the volumes our customers need at competitive pricing," the company said.
The above article was sent to subscribers in Pharmacy Daily's issue from 11 Dec 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 11 Dec 19
